Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/139578
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study
Author: Lim, W.H.
Adams, B.
Alexander, S.
Bouts, A.H.M.
Claas, F.
Collins, M.
Cornelissen, E.
Dunckley, H.
de Jong, H.
D’Orsogna, L.
Francis, A.
Heidt, S.
Herman, J.
Holdsworth, R.
Kausman, J.
Khalid, R.
Kim, J.J.
Kim, S.
Knops, N.
Kosmoliaptsis, V.
et al.
Citation: BMC Nephrology, 2021; 22(1):1-11
Publisher: Springer Science and Business Media LLC
Issue Date: 2021
ISSN: 1471-2369
1471-2369
Statement of
Responsibility: 
Wai H. Lim ... Michael Collins ... et al.
Abstract: Background: Parental donor kidney transplantation is the most common treatment option for children and adoles‑ cents with kidney failure. Emerging data from observational studies have reported improved short- and medium-term allograft outcomes in recipients of paternal compared to maternal donors. The INCEPTION study aims to identify potential diferences in immunological compatibility between maternal and paternal donor kidneys and ascertain how this afects kidney allograft outcomes in children and adolescents with kidney failure. Methods: This longitudinal observational study will recruit kidney transplant recipients aged ≤18 years who have received a parental donor kidney transplant across 4 countries (Australia, New Zealand, United Kingdom and the Netherlands) between 1990 and 2020. High resolution human leukocyte antigen (HLA) typing of both recipients and corresponding parental donors will be undertaken, to provide an in-depth assessment of immunological compat‑ ibility. The primary outcome is a composite of de novo donor-specifc anti-HLA antibody (DSA), biopsy-proven acute rejection or allograft loss up to 60-months post-transplantation. Secondary outcomes are de novo DSA, biopsyproven acute rejection, acute or chronic antibody mediated rejection or Chronic Allograft Damage Index (CADI) score of >1 on allograft biopsy post-transplant, allograft function, proteinuria and allograft loss. Using principal component analysis and Cox proportional hazards regression modelling, we will determine the associations between defned sets of immunological and clinical parameters that may identify risk stratifcation for the primary and secondary outcome measures among young people accepting a parental donor kidney for transplantation. This study design will allow us to specifcally investigate the relative importance of accepting a maternal compared to paternal donor, for families deciding on the best option for donation. Discussion: The INCEPTION study fndings will explore potentially diferential immunological risks of maternal and paternal donor kidneys for transplantation among children and adolescents. Our study will provide the evidence base underpinning the selection of parental donor in order to achieve the best projected long-term kidney transplant and overall health outcomes for children and adolescents, a recognized vulnerable population.
Keywords: Kidney transplant; Children; Adolescents; Parental donor; Immunological profle; Human leukocyte antigen; Antibody; Rejection; Allograft loss
Rights: © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
DOI: 10.1186/s12882-021-02619-0
Grant ID: http://purl.org/au-research/grants/nhmrc/1184595
Published version: http://dx.doi.org/10.1186/s12882-021-02619-0
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_139578.pdfPublished version1.17 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.